IL1B and glioblastoma: In addition, inhibition of miR-93 in GBM tumor cells fosters an inflammatory microenvironment via increasing the levels of IL-6, IL-8, IL-1β, granulocyte-colony stimulating factor, leukemia inhibitory factor, COX2, and CXCL5 (131).